Global lab company Sonic Healthcare is reportedly reviewing its Irish operations as litigation claims related to Ireland’s CervicalCheck scandal mount and the subsidiary posts falling profits. HBI examines the role of the private sector in the screening scandal and talks to a solicitor representing half of the plaintiffs. Documents seen by HBI show evidence that slides were up to 7x more likely to be misread when outsourced.
Profits at lab group Bejing Genomics Institute (BGI) are up 734% in the first half of the year after the company rapidly built 58 labs in 18 countries and sold 35m testing kits to 92% of the countries in the world for COVID-19. Yet the company is now caught up in the ever-escalating US-China trade war as two subsidiaries have been blacklisted by the States. HBI examines what this means for its global reach.
Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinics will soon be back on the market after COVID delayed a process which began earlier this year, multiple sources tell HBI. We look at the facts and figures behind the prospective sale, and speculate on multiple and price. We are told it targeted the rest of Capio Germany from Ramsay Sante before the pandemic.
In the space of a week, Amazon has launched an online pharmacy pilot in India, the country's largest retailer has retaliated by buying a controlling stake in established rival Netmeds, and the market's other two largest players - PharmEasy and Medlife - have merged to create a $1.2bn+ valued company. This is despite ongoing legislation that might ban e-pharmacies from any activity at all.
Sweden's largest telehealth player KRY will be reimbursed in Germany after it received the necessary security accreditation. Meanwhile, Docly, the spin-off from Sweden's once largest player Min Doktor, has just withdrawn its healthcare services from its only international market following slow growth.
HBI talks to Stefan Nilsson, CEO of Colosseum Dental Group, the Swiss-based pan-European chain with a presence in Finland, Norway, Sweden, Switzerland, Italy, Denmark, Germany and the UK, about how it has weathered COVID, and its plans going forward as we all adapt to the new normal.
Polish symptom checker start-up Infermedica is looking to launch in Germany after a venture capital fund set up by the country's private insurers co-led its $10.5m Series A.
Biogroup, France's largest lab group by revenue, has new Belgian shareholders after it acquired family-owned CMA-Medina, its first move outside of the home market. CEO Stephane Eimer tells HBI that the new Franco-Belgian group will make more acquisitions there and abroad.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
